Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)
Condition(s):Head and Neck Squamous Cell Carcinoma; Colorectal Cancer; Non Small Cell Lung Cancer; Epidermal Growth Factor Receptor InhibitorLast Updated:July 9, 2021Completed